LEADERSHIP, PARTNERS & INVESTORS
A WORLD CLASS LEADERSHIP TEAM
InnerPulse's corporate officers and board of directors bring a
breadth and depth of experience in technology research & development,
sales, marketing, business operations, and other areas of management with
medical device industry leaders. They have been equally successful in startup
and corporate environments.
LEARN MORE>THE EXPERTISE TO ASSURE SUCCESS
Our Technology Partners
To address the challenge of enabling our percutaneous implantable
defibrillator, the PICDT, to deliver the same operational performance as its
larger, conventional counterparts, InnerPulse has forged exclusive development
agreements with, to date, three technology leaders:
-
Greatbatch, Inc. (NYSE: GB)
- a leading developer and manufacturer of critical components of
implantable medical devices such as batteries, capacitors, stimulation leads
and therapy delivery systems. These high tech components are used in products
that service the Cardiac Rhythm Management (CRM), Neuromodulation and
Interventional Radiology markets. Greatbatch is developing an
exclusive new generation of components based on its proprietary technology for
InnerPulse. For more information, visit
www.greatbatch.com.
-
AMI Semiconductor, Inc. (NASDAQ: AMIS) -
a leading developer of low-power, mixed-signal, and wireless implantable
medical-semiconductor solutions. The company's ASIC technology will enable
InnerPulse's PICDT to provide life-saving defibrillator technology will
ultra-low-power solutions. For more information, visit
www.amis.com.
Our Investors
To date, InnerPulse has raised $85.2 million through three rounds of private
financings. Investors include:
-
Delphi Ventures-a
private venture-capital firm focusing on early-stage U.S. medical device and
biotechnology investments. Founded in 1988, the company has approximately $600
million under management and invested in more than 125 healthcare companies.
For more information, visit www.delphiventures.com.
-
Frazier Healthcare Ventures-a
venture-capital firm supporting emerging growth companies across the healthcare
industry at all stages of development, from incubation to late stage. With more
than $1 billion under management, the firm takes an active role in its
investments and has one of the largest healthcare investment teams in the
venture-capital community. For more information, visit
www.frazierco.com.
-
Johnson & Johnson Development
Corporation (JJDC)-the venture capital subsidiary of Johnson &
Johnson. JJDC makes private equity investments in venture-funded healthcare
companies. Portfolio companies include those in the fields of pharmaceuticals,
biotechnology, medical devices, diagnostics, and consumer products. Organized
in 1973, JJDC also leads and manages internal investments in selected promising
technologies. For more information, visit
www.jjdevcorp.com.
-
Medtronic, Inc.-the world
leader in medical technology providing lifelong solutions for people with
chronic disease. Medtronic offers products, therapies and services that enhance
or extend the lives of people worldwide. Each year, 5 million patients benefit
from Medtronic's technology, used to treat conditions such as diabetes, heart
disease, neurological disorders, and vascular illnesses. For more information
visit www.medtronic.com
-
Boston Scientific
Corporation - Boston Scientific's mission is to improve the quality of
patient care and the productivity of health care delivery through the
development and advocacy of less-invasive medical devices and procedures. This
is accomplished through the continuing refinement of existing products and
procedures and the investigation and development of new technologies that can
reduce risk, trauma, cost, procedure time and the need for aftercare. For more
information, visit www.bostonscientific.com
|
